JPRN-UMIN000023039
Recruiting
未知
Multicenter Clinical Performance Study to evaluate Plasma-based RAS Gene Mutation Testing using OncoBEAM RAS CRC assay (LS52R) of Patients having Progressive or Recurrent Colorectal Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sysmex corporation
- Enrollment
- 350
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patients with pathologically confirmed primary colorectal adenocarcinoma
- •2\)Patients aged 20 or older at the time of the informed consent
- •3\)Patients who signed informed consent form
- •4\)Patients whose blood collection is possible before a treatment start
- •5\)Patients confirmed Stage4 colorectal cancer by imaging findings
- •6\)Patients with no previous chemotherapy, or patients whose PD or clinical PD was confirmed before starting next treatment
Exclusion Criteria
- •1\)Patients judged ineligible to participate in the study
- •2\)Patients registered to the study in the past
- •3\)Patients with a history of multiple cancer or with a comorbid multiple cancer
- •4\)Patients with synchronous or metachronous (a disease\-free interval of five years or shorter) double cancer
- •5\)Patients with histories of treatment using drugs targeting EGFR such as an anti\-EGFR antibody or Regorafenib
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
To assess the efficacy (survivorship) of the Quadra-P Hydroxyapatite coated femoral stem in patients undergoing a primary total hip replacement surgery.Hip OsteoathritisMusculoskeletal - OsteoarthritisACTRN12620000441910Medacta Australia Pty Ltd300
Completed
Not Applicable
A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement using a Novel Point-of-Care Test Device Compared to a Reference Method in Atopic Subjectsallergic asthmaatopic asthma10006436NL-OMON44019ovartis30
Completed
Not Applicable
Multi-Centre Trial to Evaluate the Clinical Performance of the Lifetech/Medtronic Ceraflex-ASD-Occluder for Transcatheter Closure of Secundum Atrial Septal DefectsQ21.1Atrial septal defectDRKS00010233Deutsches Herzzentrum München149
Completed
Phase 4
To study the safety and efficacy of Ranibizumab of Intas Pharmaceuticals Ltd. in patients with visual impairment.Health Condition 1: H353- Degeneration of macula and posterior poleCTRI/2016/03/006739Intas Pharmaceuticals Ltd126
Completed
Not Applicable
Reduction of contrast induced nephropathy (CIN) in patients requiring a percutaneous coronary intervention procedure and have chronic renal failure.Cardiovascular disease in patients with chronic kidney disease.Renal and Urogenital - Kidney diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12612000238875Osprey Medical Pty Ltd42